Facing a deepening political crisis, PhRMA launches a major counterattack against its legion of critics
Under the most heated political attack the drug industry has ever faced on Capitol Hill, the lobbying powerhouse PhRMA is rolling out its most ambitious public relations campaign in its history.
Just months after raising dues to generate an extra $100 million for its war chest, PhRMA is reportedly spending tens of millions of dollars on a new campaign aimed to win hearts and minds in the growing battle over drug prices. PhRMA’s campaign will initially hit hard on the scientific advances that are being made, spotlighting big advances in R&D to the general public. And then they want to sponsor more discussions in public forums while pursuing their legislative agenda.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
